6 completed, 2 not yet recruiting, 1 unknown. 9 Phase 1.
By phase and status
Follow Gastritis: new trials by email Literature Review of Gastritis trials Research Report on Gastritis
Trials (filtered) newest first · largest first
All 9 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
A Study of Compare the Pharmacokinetic, Pharmacodynamic and Safety/Tolerability Characteristics Following Multiple Oral Administration of AD-234, AD-2341, and AD-2342 in Healthy Adults
AD-234, AD-2341, AD-2342 - Gastritis | Phase 1 | Not yet recruiting | 30 | 2026-08-01 | 2026-07-27 |
A Clinical Trial to Assess the Pharmacokinetics and Safety of AD-229 Compared to AD-2291 in Healthy Adults
AD-229, AD-2291 - Gastritis | Phase 1 | Not yet recruiting | 28 | 2026-04-01 | 2026-02-27 |
Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903
DW1903, DW1903-R1, DW1903-R2 - Gastritis | Phase 1 | Completed | 31 | 2020-05-15 | 2021-12-13 |
A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole
AD-206 20mg, Esomeprazole 20mg, AD-206 40mg - Gastritis | Phase 1 | Completed | 88 | 2019-06-05 | 2021-01-13 |
[KJ-INT-002] BE Study
INT-2150, Irsogladine maleate 2 mg+Nizatidine 150 mg - Gastritis | Phase 1 | Unknown | 37 | 2017-11-02 | 2018-04-26 |
A Pilot Study to Determine the Relative Bioavailability of Mosapride 5mg From Two Candidate Formulations of GR107719B Relative to One 5mg Tablet of Reference Mosapride Citrate (GASMOTIN™) in Healthy Adult Human Subjects Under Fasting Conditions
Reference mosapride citrate (GASMOTIN), GR107719B (Formulation 1), GR107719B (Formulation 2) - Gastritis | Phase 1 | Completed | 18 | 2014-02-03 | 2017-05-15 |
A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Oral Administration in Healthy Male Volunteers
PMK-S005 - Gastritis, Gastric Ulcer | Phase 1 | Completed | 37 | 2012-12-01 | 2014-05-30 |
Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer
Cetuximab - Gastric Cancer, Precancerous Condition | Phase 1 | Completed | 9 | 2001-04-01 | 2017-01-10 |
Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults
helicobacter pylori vaccine, Placebo - Helicobacter Pylori, Gastritis | Phase 1 | Completed | 113 | 2001-02-01 | 2013-06-11 |
Narrower conditions
Stomach Neoplasms (2) · Dyspepsia (1) · Gastritis, Hypertrophic (1) · Lymphoma (1) · Peptic Ulcer (1) · Precancerous Conditions (1) · Stomach Ulcer (1)
Broader conditions
Digestive System Diseases (9) · Gastroenteritis (9) · Gastrointestinal Diseases (9) · Stomach Diseases (9) · Digestive System Neoplasms (2) · Duodenal Diseases (2) · Gastrointestinal Neoplasms (2) · Intestinal Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1)
Interventions
Cetuximab (1) · Drug Evaluation (1) · Esomeprazole (1) · Nizatidine (1) · PMK-S005 (1) · irsogladine (1)
Sponsors
Addpharma Inc. (3) · Daewon Pharmaceutical Co., Ltd. (1) · GlaxoSmithKline (1) · Kukje Pharma (1) · Novartis Vaccines (1) · PharmaKing (1) · Vanderbilt University (1)
Countries
South Korea (5) · Germany (1) · India (1) · United States (1)
Top investigators
In-Jin Jang, M.D.,Ph.D (1) · Robert J. Coffey, MD (1) · Sang-Heon Cho (1)
NIH funding
P30CA068485 (1)